ArticleDrug design, development and therapy2026

Obinutuzumab as a Rescue and Maintenance Strategy in Children with Difficult-to-Treat Nephrotic Syndrome After Rituximab-Based Treatment Failure or Intolerance: A Preliminary Single-Center Real-World Retrospective Study.

Haoqiong Sun et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.